About Daniel O'Connell
Daniel O'Connell is a director at Terremoto Biosciences.
Experience
This experience comes from Daniel O'Connell's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel O'Connell in the role, so the role may have started earlier or lasted longer.
DL
DOC Consultants, LLC Current
Owner
2026 – Present
Terremoto Biosciences, Inc.
Director
2023 – 2026 · South San Francisco, CA
Develops targeted medicines for patients with cancer and genetic diseases.
KB
Kivu Bioscience
Board Chair
2024 – 2026
NH
Novo Holdings
Partner
2022 – 2026
LI
Link Immunotherapeutics
Board Member
2021 – 2023
BS
Bristol Myers Squibb
Executive Director, Equity and Venture Capital
2020 – 2022
LT
LogicBio Therapeutics
Board Member
2017 – 2020
PR
PreciThera
Board Member
2017 – 2019
HT
Harpoon Therapeutics
Board Observer
2017 – 2019
AP
Arix Bioscience plc
Investment Director
2016 – 2019
OA
OrbiMed Advisors
Private Equity
2012 – 2016
TU
Tufts University
Medical Student
2010 – 2012
TR
The Princeton Review
Premiere Tutor, MCAT
2003 – 2011
AP
Arisaph Pharmaceuticals
Associate Director, Cardiovascular Research
2007 – 2010
WY
Wyeth
Intern, Medicinal Chemistry
2002
Key Colleagues at Startups
The people Daniel O'Connell works with at each company, as listed on that company's latest Form D.
Terremoto Biosciences, Inc. · Form D, Apr 22, 2026
MG
Michael Goller
Director
GL
Grace Lu
Executive officer
James Christensen
President and Chief Executive Officer, director
Reid Huber
Partner, Third Rock Ventures and director
Peter Thompson
Co-founder and Director, Terremoto
Charles Baum
Executive Chairman